Literature DB >> 26421110

Applicability of the Existing CVD Risk Assessment Tools to Type II Diabetics in Oman: A Review.

Abdulhakeem Al-Rawahi1, Patricia Lee2.   

Abstract

Patients with type II diabetes (T2DM) have an elevated risk for cardiovascular disease (CVD), and it is considered to be a leading cause of morbidity and premature mortality in these patients. Many traditional risk factors such as age, male sex, hypertension, dyslipidemia, glycemic control, diabetes duration, renal dysfunction, obesity, and smoking have been studied and identified as independent factors for CVD. Quantifying the risk of CVD among diabetics using the common risk factors in order to plan the treatment and preventive measures is important in the management of these patients as recommended by many clinical guidelines. Therefore, several risk assessment tools have been developed in different parts of the world for this purpose. These include the tools that have been developed for general populations and considered T2DM as a risk factor, and the tools that have been developed for T2DM populations specifically. However, due to the differences in sociodemographic factors and lifestyle patterns, as well as the differences in the distribution of various CVD risk factors in different diabetic populations, the external applicability of these tools on different populations is questionable. This review aims to address the applicability of the existing CVD risk models to the Omani diabetic population.

Entities:  

Keywords:  Arabs; Cardiovascular Diseases; Oman; Risk Assessments; Type 2 Diabetes Mellitus

Year:  2015        PMID: 26421110      PMCID: PMC4576391          DOI: 10.5001/omj.2015.65

Source DB:  PubMed          Journal:  Oman Med J        ISSN: 1999-768X


  32 in total

1.  JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice.

Authors: 
Journal:  Heart       Date:  2005-12       Impact factor: 5.994

2.  Framingham, SCORE, and DECODE risk equations do not provide reliable cardiovascular risk estimates in type 2 diabetes.

Authors:  Ruth L Coleman; Richard J Stevens; Ravi Retnakaran; Rury R Holman
Journal:  Diabetes Care       Date:  2007-02-08       Impact factor: 19.112

3.  Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD).

Authors:  Lars Rydén; Eberhard Standl; Małgorzata Bartnik; Greet Van den Berghe; John Betteridge; Menko-Jan de Boer; Francesco Cosentino; Bengt Jönsson; Markku Laakso; Klas Malmberg; Silvia Priori; Jan Ostergren; Jaakko Tuomilehto; Inga Thrainsdottir; Ilse Vanhorebeek; Marco Stramba-Badiale; Peter Lindgren; Qing Qiao; Silvia G Priori; Jean-Jacques Blanc; Andrzej Budaj; John Camm; Veronica Dean; Jaap Deckers; Kenneth Dickstein; John Lekakis; Keith McGregor; Marco Metra; João Morais; Ady Osterspey; Juan Tamargo; José Luis Zamorano; Jaap W Deckers; Michel Bertrand; Bernard Charbonnel; Erland Erdmann; Ele Ferrannini; Allan Flyvbjerg; Helmut Gohlke; Jose Ramon Gonzalez Juanatey; Ian Graham; Pedro Filipe Monteiro; Klaus Parhofer; Kalevi Pyörälä; Itamar Raz; Guntram Schernthaner; Massimo Volpe; David Wood
Journal:  Eur Heart J       Date:  2007-01       Impact factor: 29.983

Review 4.  Preventing heart disease in the 21st century: implications of the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) study.

Authors:  Henry C McGill; C Alex McMahan; Samuel S Gidding
Journal:  Circulation       Date:  2008-03-04       Impact factor: 29.690

5.  Increasing prevalence of diabetes mellitus in Oman.

Authors:  J A Al-Lawati; A M Al Riyami; A J Mohammed; P Jousilahti
Journal:  Diabet Med       Date:  2002-11       Impact factor: 4.359

6.  Comparison of the Framingham and United Kingdom Prospective Diabetes Study cardiovascular risk equations in Australian patients with type 2 diabetes from the Fremantle Diabetes Study.

Authors:  Wendy A Davis; Stephen Colagiuri; Timothy M E Davis
Journal:  Med J Aust       Date:  2009-02-16       Impact factor: 7.738

7.  Major risk factors as antecedents of fatal and nonfatal coronary heart disease events.

Authors:  Philip Greenland; Maria Deloria Knoll; Jeremiah Stamler; James D Neaton; Alan R Dyer; Daniel B Garside; Peter W Wilson
Journal:  JAMA       Date:  2003-08-20       Impact factor: 56.272

8.  Diabetes mellitus in the sultanate of Oman.

Authors:  M G Asfour; S K Samantray; A Dua; H King
Journal:  Diabet Med       Date:  1991-01       Impact factor: 4.359

Review 9.  Cardiovascular risk assessment scores for people with diabetes: a systematic review.

Authors:  P Chamnan; R K Simmons; S J Sharp; S J Griffin; N J Wareham
Journal:  Diabetologia       Date:  2009-07-24       Impact factor: 10.122

10.  Performance of the UK Prospective Diabetes Study Risk Engine and the Framingham Risk Equations in Estimating Cardiovascular Disease in the EPIC- Norfolk Cohort.

Authors:  Rebecca K Simmons; Ruth L Coleman; Hermione C Price; Rury R Holman; Kay-Tee Khaw; Nicholas J Wareham; Simon J Griffin
Journal:  Diabetes Care       Date:  2008-12-29       Impact factor: 17.152

View more
  2 in total

1.  Cardiovascular Disease Incidence and Risk Factor Patterns among Omanis with Type 2 Diabetes: A Retrospective Cohort Study.

Authors:  Abdul Hakeem Al Rawahi; Patricia Lee; Zaher A M Al Anqoudi; Ahmed Al Busaidi; Muna Al Rabaani; Faisal Al Mahrouqi; Ahmed M Al Busaidi
Journal:  Oman Med J       Date:  2017-03

2.  Agreement between cardiovascular disease risk assessment tools: An application to the United Arab Emirates population.

Authors:  Abderrahim Oulhaj; Sherif Bakir; Faisal Aziz; Abubaker Suliman; Wael Almahmeed; Harald Sourij; Abdulla Shehab
Journal:  PLoS One       Date:  2020-01-24       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.